Project Grant HT94252410786
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$738K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The University of Texas Southwestern Medical Center received a $1.46 million Project Grant award from the Department of the Army Medical Command to develop a small chemical drug targeting EphB1 for the treatment of chronic pain. The grant was awarded on September 30, 2021 with a completion date of September 29, 2024. The funding supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical...
The University of Texas at Dallas (UTD) was awarded a $701,946 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 1, 2024, will support research to "TARGET MNK SIGNALING TO PREVENT AND REVERSE CHRONIC PAIN CAUSED BY COMPLEX TRAUMATIC INJURY" over a 4-year period ending on August 31, 2028. As a leading research university, UTD will leverage its expertise in areas such as...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,640,000.00 to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on the brain-to-bone and bone-to-brain axis after traumatic brain injury. The 4-year award, starting on September 1, 2025, will support advanced biomedical investigations to transform healthcare for military service members, veterans, and the...
The Department of the Army Medical Command awarded a $580,444 Project Grant to The University of Texas M.D. Anderson Cancer Center through the Military Medical Research and Development program. The grant will fund research from August 15, 2022 to August 14, 2025 to target STAT3 signaling pathways to promote recovery from neuropathic pain. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of improving military and public...
This Project Grant award, valued at $159,341 and awarded on September 30, 2024, is funded through the Military Medical Research and Development program (CFDA 12.420) of the U.S. Department of the Army Medical Command. The grant supports research at The University of Texas Southwestern Medical Center in Dallas, Texas to target the PARP1 protein as a means of overcoming castration resistance in prostate cancer. The research aims to advance new treatment approaches for this condition, which is a...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The University of Texas Southwestern Medical Center was awarded a $2,641,871 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2023 through April 30, 2027 to comprehensively upregulate and stabilize frataxin mRNA using antisense oligonucleotides. The goal of this research is to transform health care for service members and the public by investigating medical solutions for the...
This federal Project Grant award in the amount of $617,537 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, with a performance period from September 1, 2024 to August 31, 2027, supports research conducted by The University of Texas Southwestern Medical Center (UT Southwestern) to examine heterogeneity in response to disease-modifying therapy for multiple sclerosis. As a prominent academic medical center, UT...